Rockwell Medical (RMTI) furnishes new corporate presentation as Reg FD exhibit
Rhea-AI Filing Summary
Rockwell Medical, Inc. furnished an updated corporate presentation as a Regulation FD Disclosure. The presentation, dated August 13, 2026, is provided as Exhibit 99.1 and is incorporated by reference. The materials are furnished, not filed, so they are not subject to Section 18 liabilities and are not automatically incorporated into Securities Act or Exchange Act filings.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Terms
Regulation FD Disclosure, furnished, incorporated by reference, Inline XBRL
4 terms
Regulation FD Disclosure regulatory
"Item 7.01 Regulation FD Disclosure. On August 13, 2026, Rockwell Medical, Inc."
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
furnished regulatory
"A copy of the corporate presentation is furnished herewith as Exhibit 99.1"
incorporated by reference regulatory
"furnished herewith as Exhibit 99.1 and incorporated by reference herein"
Inline XBRL technical
"Cover Page Interactive Data File, formatted in INline XBRL and included"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
FAQ
What did Rockwell Medical (RMTI) disclose in this Form 8-K?
Rockwell Medical furnished an updated corporate presentation dated August 13, 2026 as Exhibit 99.1 under a Regulation FD Disclosure item, making the information broadly available to investors.
Is the Rockwell Medical (RMTI) corporate presentation considered filed with the SEC?
No. The company states the presentation is furnished, not filed, so it is not subject to Section 18 of the Exchange Act and is not automatically incorporated into other Securities Act or Exchange Act documents.
Under which item of Form 8-K did Rockwell Medical (RMTI) report this presentation?
The disclosure appears under Item 7.01, Regulation FD Disclosure, which is used for voluntarily providing information intended to ensure fair and equal access to material company communications.
What exhibits did Rockwell Medical (RMTI) include with this Form 8-K?
The filing includes Exhibit 99.1, Rockwell Medical, Inc. Corporate Presentation dated August 13, 2026, and Exhibit 104, the cover page interactive data file formatted in Inline XBRL.
Does this Rockwell Medical (RMTI) Form 8-K include new financial statements?
No. The filing lists Item 9.01 for financial statements and exhibits but only furnishes exhibits, specifically the corporate presentation and cover page data file, without additional financial statements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 13, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive offices, including zip code)
(248 ) 960-9009
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) | ||||||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol | Name of Each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
On August 13, 2026, Rockwell Medical, Inc. made available an updated corporate presentation. A copy of the corporate presentation is furnished herewith as Exhibit 99.1 and incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits The following exhibit is being furnished herewith:
EXHIBIT INDEX
| Exhibit No. | Description | |||||||
| 99.1 | Rockwell Medical, Inc. Corporate Presentation, dated August 13, 2026 | |||||||
| 104 | Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101. | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ROCKWELL MEDICAL, INC. | ||||||||
| Date: May 7, 2026 | By: | /s/ Mark Strobeck | ||||||
| Mark Strobeck | ||||||||
| Chief Executive Officer | ||||||||
